Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaPaweł K. Mazur, Jens T. Siveke|Nature Medicine|2015Cited by 414
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersPeter Horak, Klaus Schulze‐Osthoff, Christoph Heining et al.|Cancer Discovery|2021Cited by 282
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P. Fendler, Rainer Hamacher, Kim M. Pabst et al.|Clinical Cancer Research|2022Cited by 145
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expressionPhyllis F. Cheung, Jens T. Siveke, Jiajin Yang et al.|Nature Communications|2022Cited by 94
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Wolfgang P. Fendler, Rainer Hamacher et al.|Journal of Nuclear Medicine|2022Cited by 68